Почетна › Немалоклетни карцином плућа › Ilinois › Peoria
Kliničke studije za Немалоклетни карцином плућа u gradu Peoria, IL
23 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Peoria i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Тражи се учесникФаза 3
- Illinois Cancer Care ( Site 8107), Peoria
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Тражи се учесникФаза 3
- Illinois Cancer Care ( Site 7000), Peoria
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- Illinois Cancer Care, Peoria
- Illinois CancerCare- Pekin, Pekin · 9 ми удаљено
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Тражи се учесникФаза 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Тражи се учесникФаза 3
- Illinois Cancer Care, Peoria
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- OSF Saint Francis Medical Center, Peoria
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- и још 1
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
- OSF Saint Francis Medical Center, Peoria
- и још 3
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Тражи се учесникФаза 2/3
- OSF Saint Francis Medical Center, Peoria
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 1
- OSF Health Care, Peoria
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- OSF St. Francis Medical Center /ID# 281591, Peoria
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Тражи се учесникФаза 3
- Illinois CancerCare, P.C., Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Тражи се учесникФаза 1
- OSF Saint Francis Medical Center, Peoria
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
Тражи се учесникФаза 1
- OSF Healthcare System; Saint Francis Medical Center, Peoria
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- St. Francis Medical Center (OSF Healthcare), Peoria
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 ми удаљено
- Illinois CancerCare-Canton, Canton · 25 ми удаљено
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Тражи се учесникФаза 1
- OSF Healthcare Cancer Institute, Peoria
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Peoria
- Рак плућа13 студија
- Колоректални карцином12 студија
- Рак простате9 студија
- Рак дојке8 студија
- Рак панкреаса7 студија
- Метастатски карцином7 студија
- Рак (све врсте)7 студија
- Рак јајника7 студија
- Затајење срца7 студија
- Карцином ендометријума6 студија
- Akutna mijeloidna leukemija6 студија
- Меланом6 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.